OABI FY 2020 Earnings — OmniAb, Inc. Revenue & Financial Results | Market Cap Arena

OABIOmniAb, Inc.

$221M

FY 2020 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$23M+27.0% YoY

Gross Profit

$23M100.0% margin

Operating Income

-$26M-110.1% margin

Net Income

-$18M-75.5% margin

EPS (Diluted)

$-0.15

Cash Flow

Operating Cash Flow

$4M

Free Cash Flow

$2M

Stock-Based Comp.

$9M

Balance Sheet

Total Assets

$295M

Total Liabilities

$60M

Stockholders' Equity

$236M

Cash & Equivalents

$0

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$23M	$18M	+27.0%
Gross Profit	$23M	$18M	+27.0%
Operating Income	-$26M	-$13M	-96.7%
Net Income	-$18M	-$14M	-29.2%